Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-15

Clinical Trial Update: Adipose-tissue-derived Total-Stromal-cells (TOST) Therapy in Knee Osteoarthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on adipose-tissue-derived total-stromal-cells (TOST) therapy for knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOST therapy (adipose-tissue-derived total-stromal-cells)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Osteoarthritis Knees | Phase 2 | Status: COMPLETED